| 000 | 01714 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513090552.0 | ||
| 264 | 0 | _c19960624 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0143-3334 | ||
| 024 | 7 |
_a10.1093/carcin/17.2.185 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Brien, M L | |
| 245 | 0 | 0 |
_aConvergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis. _h[electronic resource] |
| 260 |
_bCarcinogenesis _cFeb 1996 |
||
| 300 |
_a185-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcyl-CoA Oxidase |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 |
_aFarnesol _xmetabolism |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xpharmacology |
| 650 | 0 | 4 |
_aLiver Neoplasms _xetiology |
| 650 | 0 | 4 |
_aLovastatin _xpharmacology |
| 650 | 0 | 4 |
_aMicrobodies _xdrug effects |
| 650 | 0 | 4 |
_aOxidoreductases _xmetabolism |
| 650 | 0 | 4 |
_aPolyisoprenyl Phosphates _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Retinoic Acid _xdrug effects |
| 650 | 0 | 4 | _aRetinoid X Receptors |
| 650 | 0 | 4 | _aSesquiterpenes |
| 650 | 0 | 4 |
_aTranscription Factors _xdrug effects |
| 700 | 1 | _aRangwala, S M | |
| 700 | 1 | _aHenry, K W | |
| 700 | 1 | _aWeinberger, C | |
| 700 | 1 | _aCrick, D C | |
| 700 | 1 | _aWaechter, C J | |
| 700 | 1 | _aFeller, D R | |
| 700 | 1 | _aNoonan, D J | |
| 773 | 0 |
_tCarcinogenesis _gvol. 17 _gno. 2 _gp. 185-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/carcin/17.2.185 _zAvailable from publisher's website |
| 999 |
_c8624481 _d8624481 |
||